MultiVu Video Feed: Anesiva Receives Fda Approval For Zingo(TM) a New, Innovative Product to Reduce Pain Associated With Needle Insertion Procedures In Children

Saturday, August 18, 2007 General News J E 4
The U.S. Food and Drug Administration (FDA) has just approved Zingo(TM)(lidocaine hydrochloride monohydrate) powder intradermal injection system,which provides rapid, topical, local analgesia to reduce the pain associatedwith venous access procedures, such as IV insertions or blood draws, inchildren ages three to 18.

For a child, a trip to the hospital can be a frightening experience, andthe stress associated with undergoing a venous access procedure such as ablood draw or IV insertion often escalates their anxiety. Each year inhospitals in the United States, approximately 18 million venous accessprocedures are performed on children.

Pain associated with blood draws and IV insertions is one of the mostcommon anxiety-provoking hospital procedures in children and often sets thetone for the entire hospital visit. In fact, a study published in the journalPediatric Nursing shows that IV insertions and blood draws are the mostfrequently reported painful events in hospitalized children. For moreinformation visit,

Preview and access this video on Pathfire DMG: Slug # 29227

Search within the PR Newswire or MultiVu section by story ID # 29227 orby headline

For technical assistance call Pathfire Customer Care at 1-888-345-0489 ore-mail

ADDITIONAL RESOURCES: Video, contact information and more available at:


Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations,1-800-653-5313 EXT. 3SATELLITE FEEDS: Friday, August 17th, 2007 Friday, August 17th, 2007 10:30 AM - 10:45 AM ET 1:45 PM - 2:00 PM ET Galaxy 26 Galaxy 26 C-Band C-Band Transponder 5 Transponder 5 Downlink Freq. 3800 Vertical Downlink Freq. 3800 Vertical Friday, August 17th, 2007 6:30 PM - 6:45 PM ET Galaxy 26 C-Band Transponder 15 Downlink Freq. 4000 Vertical

SOURCE Anesiva, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
PDA Encourages Back-to-School Dental Check-Ups
Milestone Scientific Announces 2007 Second Quarter...